Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Generic Drugs Come of Age

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.
Dec 2, 2009

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.

Safety versus Speed in Drug Development

The heightened focus on risk raises concerns about delays in approving new drugs.
Nov 2, 2009

The heightened focus on risk raises concerns about delays in approving new drugs.

New Leadership Seeks to Transform FDA

Strict enforcement, new rules, and organizational changes signal an activist tone.
Oct 2, 2009

Strict enforcement, new rules, and organizational changes signal an activist tone.

Global Health Concerns Create Business Opportunities

Health crises generate support for new vaccines and treatments for diseases found in developing nations.
Sep 2, 2009

Health crises generate support for new vaccines and treatments for diseases found in developing nations.

Pharma Girds for Healthcare Reform

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.
Aug 2, 2009

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.

Manufacturers Face New Risk-Management Requirements

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.
Jul 2, 2009

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.

FDA Commissioner Hamburg Discusses Drug Regulation

Jun 22, 2009

The new commissioner of the US Food and Drug Administration is mapping plans for turning around an agency that has been demoralized, buffeted about in the press and has lost some of the trust of the American people.

FDA Waves a Big Stick

Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.
Jun 2, 2009

Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.

The Comparative-Effectiveness Controversy

Government funding is slated to boost comparative studies of prescription drugs.
May 2, 2009

Government funding is slated to boost comparative studies of prescription drugs.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here